BIOMAT Database Logo BIOMAT Database Logo

[Use of chlotazol as an immunomodulating agent in chronic bronchitis]. 1991

A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh

A positive immunomodulatory effect was found in chronic bronchitis patients examined immunologically before and after treatment including chlotazol. T- and B-cell immunity recovered, clinical condition of the patients improved. A combination of known antimicrobial and antiinflammatory effects with an uncovered immunomodulatory one made chlotazol a valuable modality in the treatment of chronic bronchitis associated with secondary immune deficiency.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002697 Chloral Hydrate A hypnotic and sedative used in the treatment of INSOMNIA. Noctec,Hydrate, Chloral
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
[Use of chlotazol in the complex treatment of recurrent bronchitis and chronic pneumonia in children].
January 1990, Pediatriia,
A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
[Chronic bronchitis and immunomodulating therapy].
January 1987, Giornale italiano di chemioterapia,
A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
Vitamin A as an immunomodulating agent.
July 1993, Clinical pharmacy,
A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
Growth hormone as an immunomodulating therapeutic agent.
May 2000, Immunology today,
A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
[Interferon as an antiviral, antineoplastic and immunomodulating agent].
January 1980, Postepy higieny i medycyny doswiadczalnej,
A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
[Thalidomide--a possible alternative as an immunomodulating agent].
November 1989, Lakartidningen,
A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
Propofol: an immunomodulating agent.
May 2005, Pharmacotherapy,
A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
Effect of levamisole as an immunomodulating agent in trophoblastic lesions.
January 1993, Indian journal of pathology & microbiology,
A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
[The L2 larva of Toxocara canis as an immunomodulating agent].
January 1986, Annali dell'Istituto superiore di sanita,
A I Kleĭner, and L M Shmuter, and V M Makotchenko, and V A Efremova, and Ia I Khodzhaĭ, and V S Trukh
[Analysis of immunocompetent cell subpopulations in chronic bronchitis patients during the use of different immunomodulating preparations].
January 1984, Terapevticheskii arkhiv,
Copied contents to your clipboard!